CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 100 filers reported holding CULLINAN ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $936,340 | -4.4% | 103,463 | +13.6% | 0.00% | – |
| Q2 2023 | $979,881 | -5.2% | 91,067 | -9.9% | 0.00% | – |
| Q1 2023 | $1,033,761 | -0.2% | 101,052 | +3.0% | 0.00% | – |
| Q4 2022 | $1,035,514 | -11.3% | 98,153 | +7.8% | 0.00% | -100.0% |
| Q3 2022 | $1,167,000 | -0.8% | 91,067 | -0.8% | 0.00% | – |
| Q2 2022 | $1,176,000 | -10.0% | 91,776 | -26.5% | 0.00% | – |
| Q1 2022 | $1,307,000 | +289.0% | 124,909 | +474.5% | 0.00% | – |
| Q4 2021 | $336,000 | +273.3% | 21,742 | +444.5% | 0.00% | – |
| Q3 2021 | $90,000 | +80.0% | 3,993 | +103.1% | 0.00% | – |
| Q2 2021 | $50,000 | -61.2% | 1,966 | -36.4% | 0.00% | – |
| Q1 2021 | $129,000 | – | 3,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
| CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
| Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
| BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
| Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
| Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
| SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
| Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |